TrialClinical rheumatology2016

Itolizumab in combination with methotrexate modulates active rheumatoid arthritis: safety and efficacy from a phase 2, randomized, open-label, parallel-group, dose-ranging study.

Arvind Chopra et al.PubMed ↗Publisher ↗

No numbers read from the abstract.